Research programme: anti-sperm antibody - Epicyte
Alternative Names: Anti-sperm antibody research programme - EpicyteLatest Information Update: 02 Feb 2015
At a glance
- Originator Epicyte Pharmaceutical; ReProtect LLC
- Developer Dow Chemical; Epicyte Pharmaceutical; ReProtect
- Class Antibodies; Spermicidal contraceptives
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pregnancy
Most Recent Events
- 02 Feb 2015 Discontinued - Preclinical for Pregnancy (Prevention) in USA (Topical)
- 11 Mar 2003 No development reported - Preclinical for Pregnancy (Prevention) in USA (Topical)
- 08 Nov 2000 Preclinical development for Pregnancy (Prevention) in USA (Topical)